Product image of Kalinox (Nitrous Oxide, Oxygen) supplied by GNH India

Kalinox

Active Ingredient:
Nitrous Oxide, Oxygen
Origin:
EU

Kalinox (Nitrous Oxide, Oxygen)

Nitrous oxide, the active ingredient in Kalinox, is an inhalational anesthetic presented as a gas mixture for inhalation use. It provides analgesic and anxiolytic effects and is commonly employed in dental, minor surgical and obstetric settings to help manage pain and anxiety.

GNH India supplies Kalinox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, dental clinics and obstetric centres worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable logistics and responsive technical support.

Manufacturer / TM Owner

Air Liquide Sante International

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kalinox, a nitrous oxide/oxygen inhalation mixture, is used for analgesia and anxiolysis in several clinical settings.

  • Dental procedures: provides rapid analgesia and reduces patient anxiety during treatment.
  • Minor surgical procedures: offers supplemental analgesia for short, minimally invasive operations.
  • Labor and delivery analgesia: assists in managing pain during childbirth while maintaining maternal consciousness.
  • Procedural sedation: supports mild to moderate sedation for brief diagnostic or therapeutic interventions.

How It Works

  • Nitrous oxide exerts its effects primarily by antagonizing NMDA receptors, enhancing endogenous opioid release, and modulating GABAergic neurotransmission. The combined nitrous oxide and oxygen mixture produces analgesia, anxiolysis, and a mild dissociative state while preserving respiratory drive, allowing controlled sedation during short procedures.

Side Effects

Kalinox may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: transient upset stomach during or after inhalation.
  • Vomiting: occasional emesis following exposure.
  • Dizziness: light‑headed sensation that resolves quickly.
  • Headache: mild to moderate headache during recovery.
  • Dry mouth: reduced salivation while using the gas.
  • Euphoria: brief feeling of well‑being or giddiness.

Serious or Rare Side Effects

  • Hypoxia: insufficient oxygen leading to cyanosis.
  • Respiratory depression: reduced breathing effort requiring monitoring.
  • Loss of consciousness: unexpected deep sedation.
  • Severe hypotension: marked drop in blood pressure.
  • Allergic reaction: rash, itching, or anaphylaxis.
  • Vitamin B12 deficiency: prolonged exposure may impair B12 metabolism.

Precautions & Warnings

When using Kalinox, clinicians should observe several safety measures.

  • Assess patient respiratory function: ensure adequate ventilation before administration.
  • Avoid use in severe COPD or obstructive airway disease: risk of respiratory compromise.
  • Monitor oxygen saturation continuously: maintain SpO2 above safe thresholds.
  • Do not combine with other central nervous system depressants without supervision: may intensify sedation.
  • Pregnancy and breastfeeding: use only if benefit outweighs risk and after obstetric consultation.
  • Store at ambient temperature below 25°C: keep cylinder upright, protect from heat and direct sunlight.

Avoid Interactions

Kalinox can interact with other agents, requiring careful management.

Major Interactions (Avoid)

  • Concurrent use of other inhaled anesthetics: additive respiratory depression.
  • High‑flow oxygen therapy: may diminish nitrous oxide efficacy.
  • Combination with methotrexate or other chemotherapy agents: potential potentiation of toxicity.

Moderate Interactions (Monitor Closely)

  • Alcohol or sedatives: may increase depth of sedation.
  • Volatile anesthetics: may enhance hemodynamic effects.
  • Anticonvulsants: may alter nitrous oxide metabolism and clinical response.

Frequently Asked Questions

Kalinox is a nitrous oxide and oxygen gas mixture used to provide analgesia and anxiolysis during dental procedures, minor surgeries, labor and delivery, and other short‑duration interventions where rapid onset of pain relief and minimal sedation are desired.

Nitrous oxide acts by blocking NMDA receptors, stimulating the release of endogenous opioids, and enhancing GABA‑mediated inhibition. These actions together produce analgesic, anxiolytic, and mild dissociative effects while preserving respiratory drive, making it suitable for controlled procedural sedation.

The specific concentration and duration of Kalinox administration are determined by the prescribing clinician based on the patient’s age, weight, procedure type, and clinical response. No fixed dosing regimen is provided; the prescriber sets the appropriate parameters.

Kalinox may be used during pregnancy or lactation only when the expected benefit justifies any potential risk. Clinicians should evaluate maternal and fetal health, and a qualified obstetrician should be consulted before administration.

To order Kalinox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Kalinox combines nitrous oxide with oxygen, offering rapid onset analgesia and anxiolysis similar to other nitrous oxide delivery systems, but with the advantage of a built‑in oxygen component that reduces hypoxia risk. Compared with pure oxygen or volatile anesthetics, it provides lighter sedation and quicker recovery, making it ideal for short procedures.

Kalinox cylinders should be stored at ambient temperature below 25 °C, kept upright, and protected from heat, direct sunlight and physical damage. Ensure cylinders are secured to prevent tipping, and follow local regulations for medical gas storage and transport.

Kalinox is delivered via a calibrated inhalation mask or nasal hood. The clinician adjusts the nitrous oxide‑to‑oxygen ratio, typically starting at 30 % nitrous oxide, and monitors the patient’s vital signs throughout the procedure, ensuring adequate oxygenation and ventilation.

Serious risks include hypoxia, respiratory depression, loss of consciousness, severe hypotension, allergic reactions, and, with prolonged exposure, vitamin B12 deficiency. Continuous monitoring of oxygen saturation and patient responsiveness is essential to detect and manage these events promptly.

Kalinox is contraindicated in patients with known hypersensitivity to nitrous oxide or oxygen, severe chronic obstructive pulmonary disease, uncontrolled asthma, or those who are unable to protect their airway. It should also be avoided in individuals receiving certain chemotherapy agents such as methotrexate without specialist guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nitrous Oxide, Oxygen

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT